3 Reasons Intuitive Surgical, Inc.'s Stock Could Rise

Though it's been a rough year for shareholders, a new machine and other potential tailwinds could help.

Aug 15, 2014 at 4:13PM

Shareholders of Intuitive Surgical (NASDAQ:ISRG), maker of the da Vinci Surgical System, have endured a whipsaw ride over the past two years. On four different occasions, the stock has swung more than 30%.

Screen Shot

Source: YCharts.

This volatility is the result of a confluence of factors, including doctors questioning the efficacy of the da Vinci robotic surgical technology, tighter hospital budgets in the face of the Affordable Care Act, and the introduction of a new surgical machine.

But for current or prospective shareholders, there are three big reasons to remain bullish on the company's future.

A solid moat

While the healthcare industry is abuzz with innovative new technologies, the same can't be said for the act of performing surgery. While new tools and approaches constantly enter the scene, the option to have your surgery performed via a robot remains the only real alternative to traditional surgical procedures.

This doesn't mean that robotic procedures are always a better -- or more cost-effective -- alternative to traditional surgery. In 2013, several medical professionals questioned whether using the da Vinci for hysterectomies was worth the extra money involved.

At the same time, Intuitive isn't a static company. It regularly incorporates feedback from the medical community into the design of future machines. With each incremental improvement, the company creates a wider moat around its business.

A new machine ushering in new opportunities

Earlier this year, Intuitive introduced its latest iteration of the robotic surgery system: the da Vinci Xi.

Screen Shot

Source: Intuitive Surgical.

The machine presents several new options for surgeons. Most important is increased mobility, as the surgical arms can rotate to cover all quadrants of the abdomen. The Xi also offers unobstructed and enhanced visual access to the patient.

With the new machine, Intuitive can attempt to differentiate the types of procedures for which the robot is used. Historically, prostatectomies and hysterectomies accounted for the vast majority of da Vinci operations. The inherent risk with such a concentrated application became painfully obvious when hysterectomy procedure growth came under pressure last year.

The company reports procedures in "general surgery" on an annual basis. This encompasses all surgical procedures outside of the core gynecological and prostate fields. Even before the Xi was introduced, general procedures were growing quickly.

Screen Shot

Source: SEC filings

With the Xi, the growth of these types of procedures could be a major driver for Intuitive's future. In the company's second-quarter earnings release, it said that "higher procedure volume was driven by growth in U.S. general surgery procedures," and that "general surgery is now our second largest and fastest growing specialty in the U.S."

Hospitals loosening their purse strings

A reversal of business fortunes in the United States has been a major drag on Intuitive's stock. Before 2013, the company had solidly grown the number of da Vincis it sold to hospitals.

Last year, those numbers actually reversed and began to shrink. Fellow Fool Sean Williams highlighted a major reason for that reversal: the onset of the Affordable Care Act, or Obamacare.

As the effects of the legislation were largely unknown, hospitals assumed a conservative stance when it came to major capital purchases. With average selling prices of over $1 million, Intuitive's machines became far less popular.

But hospitals eventually will feel far more comfortable in forecasting their financial situation as they get more used to the legislation. And with time, I think that the benefits of the machines as noted above will be more clear.

The takeaway for investors

An investment in Intuitive isn't without its risks -- no investment is. And even if all of the possible positive events mentioned above happen, Intuitive's stock could still decline. But with a growing moat around its business, a new machine that could help perform a greater variety of procedures, and hospitals that will hopefully begin loosening their purse strings, there's a lot for investors to be excited about for this stock over the long term.

Leaked: This coming blockbuster will make every biotech jealous
Intuitive Surgical still qualifies as a growth story in healthcare.  But there are other places to look for growth as well.

There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Brian Stoffel owns shares of Intuitive Surgical. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers